- Joined
- May 30, 2015
- Messages
- 404
- Reaction score
- 83
Say you have a nuclear receptor R to which steroid hormone H binds. In an in vitro culture, you add a synthetic compound X that binds with a 1000 times higher affinity to the active (H-binding) site of R; this is observed to INCREASE mRNA transcription of the genes upregulated by H. So a few questions: 1) Is this actually a plausible phenomenon? 2) From the cell's point of view, it probably feels there's a lot of H inside the nucleus (even though there's not), right? So would this mean the cell would stop importing further H? In other words, would the H agonist (X) act exactly like H in terms of both activity and regulation?